Clinical Laserthermia Systems AB (publ) (CLS-B) — Cash Flow Reinvestment Rate
Latest as of June 2022:
0.14x
Clinical Laserthermia Systems AB (publ) (CLS-B) has a Cash Flow Reinvestment Rate of 0.14x as of June 2022, reinvesting Skr95.00K (capex Skr0.00 plus investments Skr-95.00K) from operating cash flow of Skr658.00K. Explore Clinical Laserthermia Systems AB (publ) capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.14x
(Capex + Investments) / Operating CF
Total Reinvested
Skr95.00K
Capex + Investments
Operating Cash Flow
Skr658.00K
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Clinical Laserthermia Systems AB (publ) (None–None)
Year-by-year capital reinvestment analysis for Clinical Laserthermia Systems AB (publ). For live market cap and broader valuation context, see Clinical Laserthermia Systems AB (publ) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow